Stocktoria

Annexon, Inc. ANNX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-07-24

Annexon, Inc. statistics & valuation

Market cap$897.9M
P / B4.2×
Return on equity-97.7%
Return on capital-92.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-18.40% -56.20% -61.40% -53.60% -47.20% -97.70% 2019202020212022202320242025
Shares outstanding
433749 38.2M 38.6M 54.7M 78.4M 137.4M 155.1M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-74.50% -17.80% -45.40% -49.80% -45.10% -39.50% -74.50% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$3.40 -$2.60 -$1.77 -$1.01 -$1.34 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-74.5%-39.5%-45.1%-49.8%-45.4%-17.8%-74.5%
Return on equity-97.7%-47.2%-53.6%-61.4%-56.2%-18.4%37.0%
Current ratio5.6810.3714.7211.1011.3933.339.21

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.